Topical application of mitomycin C in combination with dexamethasone: Effective delay of myringotomy closure

ORL

Volumn 68, Issue 4, 2006, Pages 185-188

  Kaftan, Holger ^a   Hosemann, Werner ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Dexamethasone; Mitomycin C; Myringotomy; Tympanic membrane; Wound healing

Indexed keywords

DEXAMETHASONE; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EARDRUM; MYRINGOTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; TIME SERIES ANALYSIS; WOUND CLOSURE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ALKYLATING AGENTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; MIDDLE EAR VENTILATION; MITOMYCIN; OTITIS MEDIA WITH EFFUSION; RATS; RATS, INBRED LEW; TREATMENT OUTCOME; TYMPANIC MEMBRANE; WOUND HEALING;

EID: 33745194657     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091393     Document Type: Article

References (24)

1. Kay DJ, Nelson M, Rosenfeld RM: Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg 2001;124:374-380.
2. Estrem SA, Batra PS: Preventing myringotomy closure with topical mitomycin C in rats. Otolaryngol Head Neck Surg 1999;120:794-798.
3. Yucel OT: Topical use of mitomycin C in laser myringotomy: an experimental study in rats. Int J Pediatr Otorhinolaryngol 2000;54:93-96.
4. O'Reilly RC, Goldman SA, Widner SA, Cass SP: Creating a stable tympanic membrane perforation using mitomycin C. Otolaryngol Head Neck Surg 2001;124:40-45.
5. Jang CH, Song CH, Pak SC: Effect of exposure to mitomycin C on cultured tympanic membrane fibroblasts. Int J Pediatr Otorhinolaryngol 2003;67:173-176.
6. Chen PP, Yamamoto T, Sawada A, Parrish RK, Kitazawa Y: Use of antifibrosis agents and glaucoma drainage devices in American and Japanese glaucoma societies. J Glaucoma 1997;6:192-196.
7. Estrem SA, Baker TJ: Preapplication of mitomycin C for enhanced patency of myringotomy. Otolaryngol Head Neck Surg 2000;122:346-348.
8. Kaftan H, Hosemann W: Topical application of mitomycin C before vs. after myringotomy: an experimental study. ORL 2006;68:73-76.
9. D'Ereditá R: Contact diode laser myringotomy and mitomycin C in children. Otolaryngol Head Neck Surg 2004;130:742-746.
10. Cankaya H, Egeli E, Kuntsal L, Ozbek H, Icli M: Effects of topical mitomycin on inner ear: a light and electron microscopic study. Tohoku J Exp Med 2002;197:81-86.
11. Jassir D, Buchman CA, Gomez-Marin O: Safety and efficacy of topical mitomycin C in myringotomy patency. Otolaryngol Head Neck Surg 2001;124:368-373.
12. Babu SC, Kartush JM, Patni A: Otologic effects of topical mitomycin C: phase I-evaluation of ototoxicity. Otol Neurotol 2005;26:140-144.
13. Spandow O, Hellstrom S. Schmidt SH: Hydrocortisone delay of tissue repair of experimental tympanic membrane perforations. Ann Otol Rhinol Laryngol 1990;99:647-653.
14. Kaftan H, Hosemann W: Systemic corticoid-application in combination with topical mitomycin or dexamethasone: inhibition of wound healing after myringotomy. HNO 2005;53:779-783.
15. Ishimoto S, Ishibashi T: Induction of growth factor expression is reduced during healing of tympanic membrane perforations in glucocorticoid-treated rats. Ann Otol Rhinol Laryngol 2002;111:947-953.
16. Schmidt SH, Hellstrom S: Tympanic membrane structure - new views: a comparative study. ORL 1991;53:32-36.
17. Kaftan H, Hosemann W, Junghans D, Göpferich A, Schindler E, Beule A: Local application of an alginate matrix loaded with epidermal growth factor for the treatment of acute traumatic tympanic membrane perforations in an animal model. HNO 2005;53:539-544.
18. Kaftan H, Hosemann W, Beule A, Junghans D: An improved animal model for chronic perforation of the tympanic membrane. HNO 2004;52:714-719.
19. Koopman JP, Reuchlin AG, Kummer EE, Boumans LJJ, Rijntjes E, Hoeve LJ, Mulder PGH, Blom HM: Laser myringotomy versus ventilation tubes in children with otitis media with effusion: a randomized trial. Laryngoscope 2004;114:844-849.
20. Ferguson B, Gray SD, Thibeault S: Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins. Laryngoscope 2005;115:110-115.
21. Ribeiro FAQ, Guaraldo L, Borges JP, Zacchi FFS, Eckley CA: Clinical and histological healing of surgical wounds treated with mitomycin C. Laryngoscope 2004;114:148-152.
22. Zanetti D, Piccioni M, Nassif N, Campovecchi C, Redaelli de Zinis LO: Diode laser myringotomy for chronic otitis media with effusion in adults. Otol Neurotol 2005;26:12-18.
23. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, Wall GM, Dupre SJ, Potts S, Hogg G, Stroman DW, McLean C: Topical ciprofloxacin/ dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2004;113:e40-e46.
24. Yilmaz I, Yilmazer C, Erkan AN, Aslan SG, Ozluoglu LN: Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission. Am J Otolaryngol 2005;26:113-117.